Plain-English translation of NCT02471378 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a laboratory study testing new vaccine candidates designed specifically to protect pregnant women and their babies from malaria. Researchers will collect blood samples from pregnant women in Mali who currently have malaria, then use those samples to test whether the new vaccines can produce the same type of protective antibodies that naturally develop in women who are repeatedly exposed to malaria over time.
Malaria during pregnancy is a serious problem that can harm both mothers and babies, causing low birth weight, anemia, and high blood pressure. Current malaria vaccines may not work well for pregnant women, so this research aims to develop better vaccine options specifically designed to protect this vulnerable group and their unborn children.
You likely qualify if…
You likely don't qualify if…
You would visit a health center in Mali for a single enrollment visit at your antenatal (pregnancy) appointment. The study team would collect a small blood sample from you, which would then be used in laboratory tests to evaluate how well the new vaccine candidates work. The study does not involve giving you any medication or vaccine—only collecting and testing your blood sample.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
Mali